Pharmacokinetics of prednisolone in children: an open-label, randomised, two-treatment cross-over trial investigating the bioequivalence of different prednisolone formulations in children with airway disease

INTRODUCTION: One in three Danish children under 3 years of age experience asthma-like symptoms, and one-third will later be diagnosed with asthma. Oral prednisolone is used in various formulations to treat acute asthma. However, the potential differences in bioequivalence between these formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslund-Krog, Sissel Sundell, Schmidt, Maria, Mathot, Ron, Kryger Jensen, Andreas, Jørgensen, Inger Merete, Holst, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782035/
https://www.ncbi.nlm.nih.gov/pubmed/31646194
http://dx.doi.org/10.1136/bmjpo-2019-000520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782035/
https://www.ncbi.nlm.nih.gov/pubmed/31646194
http://dx.doi.org/10.1136/bmjpo-2019-000520

Ejemplares similares